International Forum of Allergy & Rhinology

Papers
(The H4-Index of International Forum of Allergy & Rhinology is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Association between the HLA‐DQA1 rs1391371 risk allele and chronic rhinosinusitis506
Issue Information149
104
Issue Information79
Effect of sarcopenia on survival outcomes in patients with nasopharyngeal and sinonasal cancer76
Lateral pedicled nasoseptal flaps for bilateral frontal sinus inverted papillomas after endoscopic Draf III procedure65
Accessing the Eustachian tube: Conventional nasal spray vs. exhalation delivery system and the impact of targeted endoscopic sinus surgery on topical distribution patterns57
Phase I safety and tolerability study of topical verapamil HCl in chronic rhinosinusitis with nasal polyps53
53
Letter to the editor regarding “Intralesional cidofovir injections for the treatment of multifocal exophytic sinonasal papilloma”: The utility of topical cidofovir51
Surgical complications in combined rhinoplasty and endoscopic sinus surgery44
Letter to the editor regarding “The association between olfactory subdomains and frailty: A prospective case‒control study investigation”37
Correspondence to the editor regarding the article entitled, “The effect of PM2.5 on acute sinusitis: A population‐based study”36
Inhalational exposure history is associated with differential sinonasal gene expression profiles and clinical outcomes in chronic rhinosinusitis patients: A pilot study35
Spending, utilization, and coverage for chronic rhinosinusitis with nasal polyposis therapies among Medicare Advantage beneficiaries34
The association between olfactory subdomains and frailty: A prospective case‒control study investigation31
Responsiveness and convergent validity of the chronic rhinosinusitis patient‐reported outcome (CRS‐PRO) measure in CRS patients undergoing endoscopic sinus surgery30
Histopathologic features of biologic therapy nonresponders in chronic rhinosinusitis with nasal polyposis29
Are you congested? A comparison of definitions between otolaryngologists and their patients27
Long‐term olfactory dysfunction in COVID‐19 patients: 18‐month follow‐up study26
Odorant metabolism of the olfactory cleft mucus in idiopathic olfactory impairment patients and healthy volunteers24
Site‐specific detection and differential levels of immune mediators in the sinonasal mucosa24
EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps24
24
0.11922788619995